Generalized Pustular Psoriasis
Immunology·MeSH: Psoriasis
Prevalence
0.5 / 100K
7 drugs in development·2 companies·5 clinical trials
Drug Pipeline by Phase
Phase 3(6)
BLA Filed(1)
| Drug | Company |
|---|---|
| imsidolimab | ANAPTYSBIO, INC (ANAB) |
Compare drugs
Frequently asked questions
How many drugs are in development for Generalized Pustular Psoriasis?
BioSniper tracks 7 drugs in development for Generalized Pustular Psoriasis across 2 companies.
How many clinical trials target Generalized Pustular Psoriasis?
There are 5 clinical trials targeting Generalized Pustular Psoriasis tracked by BioSniper.
What is the prevalence of Generalized Pustular Psoriasis?
The estimated prevalence of Generalized Pustular Psoriasis is approximately 0.5 per 100,000 population.
Deep-dive into Generalized Pustular Psoriasis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis